---
figid: PMC8648636__13402_2021_632_Fig2_HTML
figtitle: Drug combination screening as a translational approach toward an improved
  drug therapy for chordoma
organisms:
- Poecilia reticulata
- Pollachius pollachius
- Homo sapiens
- Rattus norvegicus
- Matthiola incana
pmcid: PMC8648636
filename: 13402_2021_632_Fig2_HTML.jpg
figlink: /pmc/articles/PMC8648636/figure/Fig2/
number: F2
caption: Illustration of drug targets identified in the screen. Upon activation by
  growth factors, transmembrane receptor tyrosine kinases (RTKs) utilise common intracellular
  signalling pathways to modulate intracellular activities and gene expression levels.
  Examples of RTKs include the epidermal growth factor (EGF) receptor (EGFR), the
  hepatocyte growth factor (HGF) receptor (HGFR, MET), the vascular endothelial growth
  factor (VEGF) receptor (VEGFR) and the platelet-derived growth factor (PDGF) receptor
  (PDGFR) [–]. Common intracellular RTK downstream signalling pathways are, e.g.,
  the rat sarcoma (Ras)- rapidly accelerated fibrosarcoma (RAF)- mitogen-activated
  protein kinase (MEK)- extracellular signal-regulated kinase (Erk) pathway, and the
  phosphatidylinositol-3-kinase(PI3K)– protein kinase B (Akt)– mammalian target of
  rapamycin (mTOR) pathway [, , ]. Phosphatase and tensin homolog (PTEN), a tumour
  suppressor, negatively regulates Akt/mTOR signalling [, ]. Histone deacetylases
  (HDACs) modify DNA-packaging and alter its accessibility for transcription factors
  [, ]. DNA topoisomerases modify the tertiary DNA conformation and are involved in
  DNA replication []
papertitle: Drug combination screening as a translational approach toward an improved
  drug therapy for chordoma.
reftext: Susanne Scheipl, et al. Cell Oncol (Dordr). 2021;44(6):1231-1242.
year: '2021'
doi: 10.1007/s13402-021-00632-x
journal_title: Cellular Oncology (Dordrecht)
journal_nlm_ta: Cell Oncol (Dordr)
publisher_name: Springer Netherlands
keywords: Bone tumour | Chordoma | Precision medicine | Targeted therapy | EGFR inhibitor
  | Combination screen
automl_pathway: 0.8895358
figid_alias: PMC8648636__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Poecilia reticulata
redirect_from: /figures/PMC8648636__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8648636__13402_2021_632_Fig2_HTML.html
  '@type': Dataset
  description: Illustration of drug targets identified in the screen. Upon activation
    by growth factors, transmembrane receptor tyrosine kinases (RTKs) utilise common
    intracellular signalling pathways to modulate intracellular activities and gene
    expression levels. Examples of RTKs include the epidermal growth factor (EGF)
    receptor (EGFR), the hepatocyte growth factor (HGF) receptor (HGFR, MET), the
    vascular endothelial growth factor (VEGF) receptor (VEGFR) and the platelet-derived
    growth factor (PDGF) receptor (PDGFR) [–]. Common intracellular RTK downstream
    signalling pathways are, e.g., the rat sarcoma (Ras)- rapidly accelerated fibrosarcoma
    (RAF)- mitogen-activated protein kinase (MEK)- extracellular signal-regulated
    kinase (Erk) pathway, and the phosphatidylinositol-3-kinase(PI3K)– protein kinase
    B (Akt)– mammalian target of rapamycin (mTOR) pathway [, , ]. Phosphatase and
    tensin homolog (PTEN), a tumour suppressor, negatively regulates Akt/mTOR signalling
    [, ]. Histone deacetylases (HDACs) modify DNA-packaging and alter its accessibility
    for transcription factors [, ]. DNA topoisomerases modify the tertiary DNA conformation
    and are involved in DNA replication []
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - HGF
  - IL6
  - SOS1
  - TGFA
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - EGF
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EPHB2
  - MAPK1
  - MAPK3
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - EGFR
  - KDR
  - FLT1
  - FLT4
  - PDGFRB
  - PDGFRA
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - PTEN
  - Hgf
  - Tgfa
  - Egf
  - Vegfa
  - Ephb1
  - Egfr
  - Pik3cg
  - Akt1
  - Mtor
  - Pten
  - hgfb
  - tgfa
  - egf
  - egfra
  - mtor
  - ptenb
---
